Xconomy Boston

BSX CEO Buys 350K Shares

Rebecca Zacks10/10/08

Boston Scientific CEO James Tobin exercised $2.1 million worth of options on shares of the Natick, MA-based medical device firm yesterday as an “an expression of confidence in the company,” according to a report in the Boston Business Journal. The CEO’s purchase of 350,000 shares of Boston Scientific (NYTS:BSX) stock at $6.13 per share followed on the heels of co-founders Pete Nicholas and John Abele’s involuntary sale of about about 13 million shares as part of an automatic selling plan. Shares of Boston Scientific are trading at $7.31 at around 1:00 pm EST; the 52-week low for the stock is $8.10.

Add Your Thoughts

You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted.
By clicking "Publish," you are agreeing to these Terms and Conditions.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.